ICON PLC (ICLR)
ICON PLC is a Dublin, Ireland-based life sciences company listed on NASDAQ as common stock under the ticker ICLR. The company operates as a clinical research organization, supporting outsourced development and commercialization activities for clients in the pharmaceutical, biotechnology, and medical device sectors, as well as government and public health organizations. Its services span the clinical development process, from early compound selection through Phase I to Phase IV studies, and include trial management, consulting, contract staffing, data solutions, and site and patient access support. ICON also provides laboratory capabilities such as bioanalytical, biomarker, vaccine, GMP, and central laboratory services, along with adaptive trial, cardiac safety, decentralized and hybrid trial, medical imaging, and real world intelligence solutions. Founded in 1989, the company serves customers in Ireland, Europe, the United States, and other international markets.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-ICLR
|
$230.17
|
38.9% Upside
|
Undervalued
|
$181.81
|
9.7% Upside
|
Fair
|
Good
|
—
|
—
|
—
|
0.0%
|
July 29, 2026
|
73.4x
|
1.4x
|
1.5x
|
12.73 B
|
15.495 B
|
21.8%
|
99.6%
|
8.4
|
—
|
438.0%
|
